Full Text View
Tabular View
No Study Results Posted
Related Studies
Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT)
This study is currently recruiting participants.
Verified September 2010 by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study NCT01204333   Information provided by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

First Received on September 15, 2010.   Last Updated on September 17, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sinus Thrombosis, Intracranial
Additional conditions recognized in this trial
Intracranial Thrombosis
Thrombosis
Venous Thromboembolism
Venous Thrombosis
More general conditions related to this trial
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Embolism and Thrombosis
Intracranial Embolism and Thrombosis
Nervous System Diseases
Thromboembolism
Vascular Diseases
Interventions listed in this trial
Endovascular thrombolysis
Heparin
Additional drug interventions recognized in this trial
Tissue Plasminogen Activator
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Dutch Heart Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services